Author: Joe

Site Admin.
Posted on by

Feeding Your Plant From the Inside Out: What Sucrose Stem Infusion Could Mean for Your Yields

Feeding Your Plant From the Inside Out: What Sucrose Stem Infusion Could Mean for Your Yields | The Certified
The Grower's Connect
Plant Science · Yield Optimisation

Feeding Your Plant From the Inside Out: What Sucrose Stem Infusion Could Mean for Your Yields

New peer-reviewed research out of the University of Ljubljana has shown that injecting a sucrose solution directly into cannabis stems during flowering can significantly boost flower mass and cannabinoid output — without disrupting photosynthesis.

The Grower's Connect  ·  March 2025  ·  8 min read
31% Increase in flower dry mass
34% Increase in cannabinoid yield
0.5 bar Optimal infusion pressure

As a grower, you've probably heard every pitch for squeezing more out of your plants — from specialist bloom boosters to light spectrum tweaks to microbial inoculants. Most of them promise a lot and deliver a little. So when a peer-reviewed study lands showing yield improvements of 31% in flower dry mass and 34% in cannabinoid output, it's worth sitting with it for a minute.

The technique is called Plant Stem Infusion of Sucrose — PSIS for short. It's been studied in maize, barley, soybean and sweet potato for decades, but this is the first time researchers have applied it directly to cannabis. The results, published in Industrial Crops & Products (2025), are genuinely interesting — not because PSIS is going to replace your current nutrient program, but because it opens up a real conversation about how we deliver energy to flowering plants.

Let's break it all down.

What Is Plant Stem Infusion, and Where Did It Come From?

The concept is simple: rather than feeding your plant through its roots or leaves, you inject a solution directly into the stem — bypassing surface uptake entirely and delivering nutrients straight into the plant's vascular system. Think of it like an IV drip for your plant.

The method has its roots in tree care. Arborists have been injecting fungicides, insecticides and minerals into trees for decades to treat everything from Dutch elm disease to emerald ash borer infestations. The logic is solid — if the roots or bark are compromised, go around them. The same principle has since been applied to crops, with boron and calcium injections in soybeans shown to improve pod development and overall yield as far back as 1987.

Sucrose specifically became the focus of PSIS research because of what sugar does for a plant beyond just being fuel. It acts as a signalling molecule, influencing gene expression, secondary metabolism, and cellular differentiation. When you introduce exogenous sucrose at the right moment and concentration, you're not just giving the plant more energy — you're potentially pushing it toward more productive metabolic pathways.

"Sucrose doesn't just feed the plant — it talks to it. At the right concentration, it can upregulate the same pathways responsible for producing secondary metabolites like cannabinoids."

How the Study Was Set Up

The research team at the University of Ljubljana grew 72 plants of a single CBD-dominant variety — Charlotte's Angel® (chemotype III: high CBD, low THC) — in a controlled indoor environment. Two variables were tested: the concentration of the sucrose solution (0%, 7.5%, 15%, and 30%) and the pressure at which it was delivered (0.5 bar, 1 bar, and 2 bar).

Starting on day 70 of the grow (two days into flowering), a standard 20-gauge hypodermic needle was inserted diagonally into the lowest node of each test plant, connected via IV tubing to a pressurised PVC tube filled with the sucrose solution. The system stayed live for the remainder of the grow — right through to harvest on day 133. Nine plants served as a negative control group with no infusion at all.

Measurements taken included plant height, stem and organ dry mass, chlorophyll content, net carbon assimilation, stomatal conductance, respiration, and cannabinoid yield via HPLC analysis of the top inflorescence of each plant.

Study Design at a Glance

  • 72 plants total, single CBD-dominant variety (Charlotte's Angel®)
  • Infusion began day 70 — two days after flip to 12/12
  • Three pressure levels: 0.5 bar, 1 bar, 2 bar
  • Four sucrose concentrations: 0%, 7.5%, 15%, 30% (w/v)
  • System ran continuously through harvest at day 133
  • Cannabinoid analysis via HPLC — 16 cannabinoids profiled

What the Numbers Actually Showed

The Pressure Variable Was Everything

Here's the single most important takeaway: pressure matters more than concentration. Plants infused at 0.5 bar were the clear winners across almost every metric. They grew taller, produced significantly more flower dry mass, heavier stems, and delivered the highest cannabinoid yields. Everything above that — 1 bar and 2 bar — started working against the plant.

At 2 bar, cannabinoid yield actually dropped below the control group at certain sucrose concentrations. The plants were being overwhelmed. Think about it from a physiological standpoint: too much pressure forces too much solution into the vascular system too quickly. Instead of a gentle boost, you're creating mechanical and osmotic stress. The plant has to work to deal with it rather than benefit from it.

Flower Mass and Cannabinoid Yield

At 0.5 bar combined with 15% or 30% sucrose concentration, flower dry mass increased by up to 31% and total cannabinoid yield per plant jumped by up to 34% compared to the control group — both statistically significant results. These aren't marginal improvements. On a commercial scale, a 34% increase in cannabinoid yield per plant, without any change to genetics, lighting, or nutrient program, is a considerable number.

The dominant cannabinoid in the study was CBDA, which ranged from 10.72% to 12.42% across all groups, with no statistically significant difference between treatments in terms of cannabinoid profile — meaning the ratio of compounds didn't shift, just the total output. The plant was producing more of the same thing, not a different thing.

What About Leaf Mass?

Interestingly, all treated groups showed a reduction in leaf biomass compared to the control — though the difference wasn't statistically significant. This tracks with findings from other PSIS research: when you introduce exogenous sucrose, the plant reduces its reliance on photosynthesis. The leaves are doing less of the heavy lifting. This could partly explain why flower and stem mass went up while leaf mass edged down — the plant was redirecting energy rather than generating more of it.

Physiology: Mostly Business as Usual

One of the more reassuring findings is what didn't change. Net carbon assimilation, stomatal conductance, chlorophyll content, and photosynthetic efficiency all showed no statistically significant differences between treated and control plants. The infusion wasn't breaking anything in the plant's normal operating system.

The one exception: plants infused at 1 bar showed a significant increase in respiration on the first measurement day. More sucrose being pushed in means more metabolic activity — the plant was burning more energy to process the extra input. This wasn't observed at 0.5 bar, which again points to that gentler pressure being the sweet spot.

Key Finding

At 0.5 bar — the lowest pressure tested — plants received less total solution volume than higher-pressure groups, but showed the greatest yield improvements. More is not always more. The delivery rate matters as much as the dose.

Why Sucrose? The Plant Science Behind the Method

Sucrose is the primary sugar that plants move around internally. When your leaves photosynthesise, they produce sucrose and ship it through the phloem to wherever the plant needs energy most — growing shoot tips, developing fruits, building roots. During flowering, the demand from inflorescences is enormous.

By supplying sucrose exogenously via the stem, the researchers were essentially supplementing that internal supply chain at a critical moment. But sucrose does more than carry energy. It's been shown to trigger the accumulation of secondary metabolites — flavonoids, phenolic acids, anthocyanins — in various plant species. In cannabis, the same logic applies to cannabinoids, which are secondary metabolites produced under specific stress and signalling conditions. More sucrose, delivered at the right time, appears to nudge the plant toward ramping up cannabinoid biosynthesis alongside the increased biomass production.

The researchers note that sucrose also influences the activity of SnRK1 — a protein kinase involved in carbohydrate metabolism and starch production. Higher sucrose availability can upregulate the pathways responsible for biomass accumulation and overall yield.

The Honest Limitations — What This Study Doesn't Tell Us

This is a pilot study. The researchers are upfront about that. It used a single variety, a single genotype, in a single controlled environment. Before PSIS becomes something any commercial grower should seriously consider rolling out, a few questions need answers:

Does it work across chemotypes? Charlotte's Angel is a chemotype III — high CBD, low THC. High-THC varieties may respond differently. The research team specifically flags this as a priority for future work.

What's the optimal sucrose concentration? The study found that concentration alone didn't produce statistically significant differences across the groups — the benefit came from the combination of low pressure and higher concentration. There's likely a more refined sweet spot that further research could identify.

How does it scale? 72 plants in a 12m² controlled chamber is a tightly managed experiment. Adapting the injection system for a large commercial canopy — with consistent needle placement, sealed injection sites, and sterile media — is a real engineering and labour challenge. The researchers acknowledge this openly.

Contamination risk. A sucrose-rich environment inside plant tissue is a potential invitation for fungal pathogens. Sterile needles and sterilised solution would be non-negotiable in any practical application.

What This Could Mean for Growers Going Forward

Let's be real — most home growers and small-scale craft operators aren't about to start injecting their plants with IV drips this season. But that's not the point. The value of research like this is in what it tells us about how cannabis plants work, and what possibilities exist on the horizon for cultivation technology.

For commercial operations with high-value crops, even the research question here is worth watching. Cannabis is, as the study points out, one of the most valuable crops per gram of inflorescence biomass on the planet. A 30%+ yield improvement, if it translates reliably across varieties and environments, changes the economics of a grow room in a serious way. The additional cost of the infusion system, sterile supplies, and labour could absolutely be justified at commercial scale if the yield data holds up.

For the rest of us, the broader principle is useful: the timing and mechanism of nutrient delivery matters. The plant doesn't just care what you're giving it — it cares how, when, and at what rate it arrives. This study is another reminder that innovation in cannabis cultivation doesn't always come from a new bottle on the shelf. Sometimes it comes from asking fundamentally different questions about how plants work.

"Cannabis is one of the most valuable crops per gram of inflorescence biomass. Even a modest, consistent yield improvement justifies a serious look at this technology."

The Bottom Line

PSIS isn't ready for your grow room yet. But this research lays a genuinely solid foundation. The methodology is rigorous, the results are statistically significant where they count, and the researchers are appropriately careful about what the data does and doesn't say.

The key findings are clear: low pressure (0.5 bar) with a high sucrose concentration (15–30%) delivers meaningful improvements in flower dry mass and cannabinoid yield. High pressure works against the plant. The photosynthetic system remains largely intact. And the mechanism — sucrose as both energy source and signalling molecule — is well-supported by plant science literature across multiple species.

As the legal cannabis market matures and competition increases, growers who stay close to the science are the ones who will find the edges that matter. This is one worth keeping an eye on.

Source Study: Zupančič, K., Zupančič, L., Bitežnik, L., Malík, M., Lenarčič, D., & Flajšman, M. (2025). Enhancing yield of cannabis inflorescences and cannabinoids through plant stem infusion of sucrose: A novel cannabis cultivation approach. Industrial Crops & Products, 228, 120880. University of Ljubljana, Biotechnical Faculty, Department of Agronomy. Published March 2025.
The Certified — The Grower's Connect  ·  thecertified.co.za
Posted on by

Outdoor Cannabis in March: Preparing for the Flowering Stretch in South Africa

flowering stretch

February is winding down, and if you are growing cannabis outdoors in South Africa, you can feel the change in the air. The intense summer heat is beginning to mellow, the mornings are slightly crisper, and the days are getting shorter. For the cultivator, this signals the most critical phase of the lifecycle: The Transition to Flower.

While the last few months have been about vegetative growth and enjoying the culture, March demands a shift in focus. It is time to get serious. To maximize your yield and ensure a mould-free harvest, you need to understand exactly what is happening inside your plants right now.

Recent scientific research has changed how we view this phase. According to a groundbreaking study on Cannabis sativa architecture, “flowering” isn’t just about buds appearing; it is a massive architectural renovation of the plant. Here is what you need to know to get your garden ready for the Autumn bloom.

The Science of the Shift: It’s Not Just About Light

Most growers assume that as soon as the light hits 12/12, the plant simply decides to flower. However, the study “Architecture and Florogenesis in Female Cannabis sativa Plants“ reveals that the process is far more complex. Understanding Florogenesis (flower formation) will help you stop guessing and start growing with precision.

1. The Myth of the “Pre-Flower”

Have you noticed small calyxes with white hairs (stigmas) at the nodes of your branches even though the days are still long? Many growers mistake this for the start of the flowering stage.

The research shows that these Solitary Flowers are actually day-neutral. This means their appearance is triggered by the age of the plant, not the sun. A mature plant will produce these solitary flowers regardless of the light cycle. Seeing them is a good sign—it means your plant is sexually mature—but it does not mean the true flowering stretch has begun.

2. The Compound Raceme: Flowering is Branching

The most significant finding for growers is that the short-day photoperiod (which we approach in March) triggers intense branching, not just bud formation.

When the plant detects the shortening days, it stops growing tall (monopodial growth) and transforms its shoot tips into what scientists call a Compound Raceme.

  • What is it? The plant begins producing compressed, miniature branches packed tightly together.
  • The Phytomer: The “bud” you see is actually made up of hundreds of basic units called phytomers (reduced sugar leaves, bracts, and flowers) stacked in a condensed spiral.

This means that during the March transition, your plant is frantically building a new, heavy internal structure.

flowering stretch

Your March Grow Guide: 4 Steps to a Massive Harvest

Now that we understand that the plant is undergoing a structural overhaul, here is your checklist to support this architectural shift.

1. Inspect the Apex, Not the Nodes

Stop looking at the bottom of the branches for signs of flowering. To catch the transition early, look at the apical meristem (the very tip of the main shoots).

  • What to look for: When the growth at the tip becomes tight, clustered, and intricate, the plant is building its compound raceme. This signals the start of the “stretch.”
  • Action: This is your last chance to do any final training. Once these tips harden into structure, the plant’s shape is set.

2. Structural Support is Mandatory

Because the plant is about to build heavy, condensed branches, it needs physical support. The architectural shift identified in the study proves that the plant becomes top-heavy.

  • Action: If you haven’t installed netting (SCROG) or staked your plants, do it immediately. March winds in South Africa can be brutal. Support the structure now, because you won’t be able to lift heavy colas later without stressing the plant.

3. Adjust Nutrition for Branching (Don’t Dump the Nitrogen Yet)

A common mistake in March is cutting out Nitrogen (N) too early and switching straight to a Bloom Booster (P-K).

  • The Science: Since the transition involves rapid, condensed branching, the plant still requires Nitrogen to build this new structure.
  • Action: Switch to a transition feed. You need a balanced diet that supports structural growth (Nitrogen) while introducing the Phosphorus and Potassium needed for the early reproductive phase. Starving the plant of N now will result in weak branches that cannot support heavy flowers.

4. Maximise Resin Surface Area

The research noted that glandular trichomes (the resin factories containing THC and Terpenes) appear most profusely on the perigonal bracts (the leaf-like tissue casing the ovary).

  • The Goal: A healthier architectural structure produces more bracts. More bracts equal more surface area for resin.
  • Action: Ensure decent airflow and low humidity around your plants. This prevents mould and allows the plant to focus energy on producing these resin-rich bracts rather than fighting off pathogens.
flowering stretch

Conclusion: Respect the Architecture

As we head into March, look at your outdoor crop with fresh eyes. They aren’t just “making flowers”; they are rebuilding their entire internal architecture to support the next generation.

By respecting this biological process—supporting the structure, timing your nutrients, and knowing what to look for—you are setting yourself up for a successful, heavy harvest in May.

Happy Growing, South Africa. Let the season begin.

Posted on by

The Green Giant Visualising South Africa’s Cannabis Appetite

south african cannabis

Every day, countless South Africans wake up, grind a bud, and spark a flame. It’s a ritual woven into the fabric of our nation, spanning cultures, classes, and corners of the country. But have you ever stopped to consider the sheer scale of it?

Let’s run a thought experiment. It’s 2026, and we’re standing on the shoulders of data from nearly two decades ago. Back in 2008, estimates put the number of cannabis users in South Africa at around 2.4 million. The world has changed since then. Decriminalisation happened. The culture exploded. Stigma is fading. It’s safe to assume that number has grown significantly, but for the sake of this exercise, let’s stick to a conservative estimate of 3 million users today.

Now, imagine each of those people consumes just one gram a day. That’s a modest average; some smoke far less, others far more. But do the math:

3 million people x 1 gram = 3 million grams of cannabis consumed every single day.

What Does 3 Million Grams Look Like?

Three million grams is 3,000 kilograms, or 3 tonnes.
That number is hard to visualise. So, let’s put it into perspective.

  • An African Elephant: A fully grown male African elephant weighs about 6 tonnes. So, every two days, South Africa smokes an entire elephant’s weight in weed.
  • A Toyota Hilux: A double-cab bakkie weighs around 2 tonnes. We are smoking one-and-a-half Hiluxes every day.
  • A Shipping Container: A standard 20-foot shipping container can hold about 20-25 tonnes of cargo. It would take South Africa just over a week to smoke through a container filled to the brim with cannabis.

This is the daily appetite of a nation. It’s a staggering volume of plant matter being cultivated, harvested, cured, transported, and consumed. And remember, this is likely a low-ball estimate.

south african cannabis

The Mystery of the Supply Chain

How did we get here? How does a country produce and distribute 3 tonnes of a flower every day, largely within a legal grey area?

It speaks to the incredible resilience and ingenuity of the cannabis community. Long before the 2018 Constitutional Court ruling, before the “Cannabis for Private Purposes Act,” this network existed. It thrived in the shadows, built on handshake deals and hidden crop fields in the Transkei, the mountains of KZN, and indoor setups in suburban garages.

It is insane to think that despite this massive volume, there are still pockets of our country where access is difficult. There are still people taking immense risks, driving bakkies laden with bags down back roads at midnight, to get this plant to where it needs to be. The sheer logistics of moving 3 tonnes of product daily, without a formal, regulated distribution network, is a marvel of informal economics.

The Bottom of the Bottle?

Here’s the kicker: compared to alcohol, we are still the underdogs. South Africans consume millions of litres of beer and spirits annually. The alcohol industry is a titan, with trucks, warehouses, and tax revenues to match. Cannabis users, despite our numbers, are often still treated as the fringe.

Yet, when you quantify our usage, the reality becomes undeniable. We are not a fringe group. We are a massive, thriving market. We are a demographic that consumes tonnes of product daily.

Room to Grow

It has only been 8 years since decriminalisation began to shift the landscape. In that short time, we have carved out spaces for ourselves. We have cannabis clubs, grow shops, and online communities. We have events like the Amber Cup, celebrating the pinnacle of extraction.

But as we look at the sheer volume, those 3 tonnes a day, it becomes clear how much room there is for improvement. We need better standards. We need quality control that matches the volume. We need a system where access isn’t a gamble but a guarantee.

Currently, the market is a mixed bag. You can find top-shelf indoor hydro in Sandton and bush weed in a matchbox in the rural areas. There is something for everyone, which is beautiful in its own way, but imagine if we could elevate the baseline? Imagine if every one of those 3 million grams was clean, safe, and grown with care.

south african cannabis

The Great Cloud

Let’s end our thought experiment with a final image.
If all 3 million of us decided to spark up at the exact same moment, say, 4:20 PM on a Friday, what would happen?

3 million joints are lighting up simultaneously. 3 million lungs exhaling a cloud of blue-grey smoke.

It wouldn’t just be a haze; it would be a weather system. A massive, fragrant cloud drifting over Johannesburg, or blanketing Table Mountain. It would be a visual testament to our numbers, a signal that we are here, we are many, and we are united by this plant.

The market is huge. The potential is limitless. And we are just getting started.

south african cannabis

Happy Smoking, South Africa. That’s a lot of weed

Posted on by

Red Tape on Green Gold: The New Draft Cannabis Regulations & The Fight for Logic

cannabis regulations

This week, the South African Parliament decided to kick the hornet’s nest. Just as we were settling into the rhythm of the 2026 grow season, the Department of Justice and Constitutional Development (DoJCD) dropped the Draft Regulations for the Cannabis for Private Purposes Act and opened them for public comment.

Naturally, the community is buzzing and not in a good way. The “cot has been turned upside down,” as it were. While I had planned to discuss cultivation techniques today, it is my duty as your weekly commentator to pivot. We need to talk about paperwork, policy, and why the line in the sand is being drawn in some very strange places.

The New Numbers: 5 Plants, 750 Grams

We know that the Cannabis for Private Purposes Act (Act No. 7 of 2024) was signed into law, solidifying our constitutional right to cultivate, possess, and consume in private. However, the regulations, the fine print that tells the police what to look for, were missing. Until now.

Here is what the Government Gazette (No. 50744, published June 2024, open for comment Feb 2026) is proposing:

  • Cultivation Limit: A maximum of 5 plants per adult in a private place. This applies regardless of the size, shape, or strain of the plant.
  • Possession Limit: Maximum of 750 grams of cannabis per adult. Crucially, the draft implies this limit applies to both private spaces (your home) and public spaces (what you carry on you).
  • Transport: You may transport up to 750g, but it must be concealed from public view (in the boot or a storage container).
  • Vehicles: No smoking in vehicles on public roads. Passengers must conceal their stash. Drivers are essentially obligated to police their passengers.

The Big Question: Where is the Science?

The immediate reaction from the streets is anger. But we need to move past anger into constructive interrogation.

The most glaring issue with these regulations is the arbitrary nature of the limits. As a community, we need to ask the Minister of Justice a simple question, echoed by legal experts and activists alike: What is the scientifically justified rationale behind these numbers?

Why is 5 plants the magic number? If I grow 6 plants to ensure I have a steady supply of medicine for the year, why does that sixth plant make me a criminal?
Why 750 grams? To the uninitiated, or the media outlets running headlines like “Enough for 2,000 joints,” this sounds like a mountain of weed. But any grower knows that wet weight vs. dry weight matters. A massive outdoor tree can yield over a kilogram. Does harvesting one successful plant instantly turn a law-abiding citizen into a criminal because their harvest weighed 800g?

cannabis regulations

The State must provide a science-based rationale to show that these limitations are necessary and reasonable. Currently, it feels like they pulled numbers out of a hat. We don’t limit how many bottles of wine a connoisseur can keep in their cellar. Why are we limiting the harvest of a gardener?

Apathy is our Enemy

Here is the hard truth: We are letting ourselves down.

I have noticed a trend where the community is quick to complain in WhatsApp groups or Facebook comments, but slow to participate in the actual legislative process. Marching in the streets makes for good photos, but policy is written in boardrooms based on written submissions.

The deadline for comments is 5 March 2026.

There are templates available (like the one circulating from the Cannabis Culture of South Africa) that help you ask these hard questions. They challenge the constitutionality of the police inspecting your private space to count your plants. They challenge the violation of privacy. They challenge the limitation of your right to access health and food (yes, hemp seeds are food).

If we do not flood the Department’s inbox with intelligent, respectful, and firm objections, we are essentially consenting to these arbitrary rules.

The Media Spin

We also have to contend with the media narrative. The headlines focus on the “generosity” of the 750g limit, framing it as a boon for stoners. They fail to understand the agricultural reality.

Furthermore, the regulations around driving are severe. The draft proposes a zero-tolerance approach or extremely low limits for THC in the blood for drivers (comparable to 0.02g alcohol). While we all agree that impaired driving is wrong, we also know that THC stays in the blood long after impairment fades. Are we setting up a system where a daily medicinal user can never legally drive a car, even when sober?

cannabis regulations

The Reality: The Culture Precedes the Law

Ultimately, we must remember one thing: The Cannabis Community existed before the legislation.

We were growing, sharing, and healing long before the Constitutional Court judgment in 2018. We survived total prohibition. We will survive bad regulations.

However, we shouldn’t have to just “survive.” We should be allowed to thrive. We shouldn’t have to worry that a successful harvest will put us in handcuffs because we exceeded an arbitrary gram count.

The law is trying to fit a square peg (a complex, diverse culture and agricultural crop) into a round hole (a strict, policing-heavy framework). It is up to us to pick up the sandpaper and smooth out the edges.

Do not just read this and scroll on. Find the template. Write to the Department. Ask them why 6 plants are a crime. Ask them to show you the science.

The deadline is 5 March. Let’s make sure they hear us.

Posted on by

The Budtender Dilemma: South African Cannabis Retail

Budtender

The cannabis landscape in South Africa is evolving faster than a hydroponic grow cycle. Two years ago, we celebrated the sacred, trust-based relationship between the consumer and their “plug”, a connection rooted in community, reliability, and often, deep friendship. Last week, we explored the booming retail revolution, with neon-lit dispensaries popping up on every corner, navigating the legal grey areas between Section 21 prescriptions and private club memberships.

Today, we need to talk about the crucial link between these two worlds: The Budtender.

As walk-in stores become the new norm, the person behind the counter holds the keys to the kingdom. They are the gatekeepers of knowledge, the curators of experience, and, ideally, the new face of trust. But walk into five different shops today, and you’ll likely get five vastly different experiences. The question we need to ask is: Are we sacrificing connection for commerce?

The Knowledge Gap: When the Vibe Doesn’t Match the Vine

We’ve all been there. You walk into a beautifully designed space, polished glass, slick branding, maybe even a coffee bar in the corner. The vibe is immaculate. But the moment you engage the budtender, the illusion shatters.

Instead of a knowledgeable guide, you’re met with blank stares or generic sales pitches. You ask about the terpene profile of a specific strain, looking for that limonene zest to spark creativity, and you get a shrug. Or worse, you ask for something simple, to just smell the flower, and you’re met with a lecture on cannabinoids you didn’t ask for.

This disconnect is happening too often. The “Green Rush” has brought a wave of enthusiasm, but it has also brought a rush to open doors before ensuring the staff inside are equipped to open minds. It’s akin to walking into a high-end cocktail bar and finding a bartender who doesn’t know the difference between whiskey and gin. If we expect expertise from someone pouring a drink, shouldn’t we demand even more from someone dispensing medicine?

joints bongs and pipes

The “Over-Eager” Expert vs. The Overwhelmed Rookie

The problem seems to swing between two extremes.

On one end, you have the Over-Eager Expert. They mean well, armed with buzzwords and rehearsed spiels about the entourage effect and beta-caryophyllene. But sometimes, you just want to buy a gram of something that smells like petrol and pine. The art of budtending isn’t just about knowing facts; it’s about reading the room. It’s about understanding that for some, cannabis is a science, but for others, it’s a simple ritual.

On the other end, we see the Overwhelmed Rookie. Often young, enthusiastic, but thrown into the deep end without a lifejacket. They might be working for minimum wage in a shop struggling to cover its massive overheads. They are tasked with selling a complex agricultural product with medicinal properties, yet they haven’t been given the training or the pay to do it justice.

The Cost of Expertise

Here lies the crux of the issue: Knowledge has a price tag.

True expertise, the kind possessed by the legacy growers and the veteran plugs who have served our communities for decades, is valuable. These are people who understand the plant intimately, who know the difference between a cure that locks in flavour and one that breeds mould. They know their clients’ needs because they’ve built relationships over years, not minutes.

But for many new shop owners, the financial reality of running a legal(ish) dispensary is harsh. Rent, security, licensing (or legal defence) costs pile up. In the scramble to make margins, hiring an experienced, well-paid connoisseur often falls down the priority list. The result? A retail experience that feels transactional rather than transformational.

Cannabis Sativa L

Bridging the Gap: A Call to Owners and Budtenders

So, where do we go from here?

To the Shop Owners: Your staff are your most valuable asset. Investing in their education is investing in your customer’s loyalty. A beautiful shop might get someone in the door once, but a budtender who listens, understands, and guides them correctly will bring them back forever. Don’t just hire bodies; hire passion. And pay for it.

To the Budtenders: You are the new ambassadors of this plant. Take that responsibility seriously. Learn the difference between Indica and Sativa, yes, but also learn to listen. If a client wants to know about terpenes, geek out with them. If they just want to smell the jar and buy a pre-roll, respect that ritual. You are the bridge between the grower’s hard work and the consumer’s experience.

To the Community: Be patient, but be discerning. Support the shops that get it right. If you find a budtender who knows their stuff, who treats you with the same warmth and respect as your old plug, which in all fai hold onto them. Tell the owner. Let them know that expertise matters.

The transition from the street corner to the storefront was never going to be seamless. But if we want the South African cannabis industry to thrive, to be more than just a cash grab, we need to ensure that the heart of the culture, the human connection and deep respect for the plant, remains beating behind every counter.

Posted on by

Vaporising the Myths: A Deep Dive into Cannabis Vape Quality

cannabis vape

Last week, we confronted the synthetic ghost of HHC haunting our shelves. A sobering reminder that not all cannabis products are created equal. This encounter naturally leads us to a broader, equally critical conversation: the world of cannabis vape cartridges.

Vaping has exploded in popularity, offering a discreet, convenient, and potent way to consume. But walk into any dispensary, and you’re met with a dizzying array of options. “Live Resin,” “Live Rosin,” “Distillate,” “Full Spectrum” the labels can be confusing. And let’s be honest, sometimes the experience is a letdown. A cart that tastes like artificial candy, leaks, or simply doesn’t deliver the promised effects can turn anyone off.

This week, we’re pulling back the curtain on vape production. We’ll explore the science of extraction, specifically fractional distillation, decipher the differences between premium and subpar products, and arm you with the knowledge to make better decisions. Because when it comes to vapes, knowing how it was made is just as important as what is in it.

The Engine of Consistency: Understanding Fractional Distillation

At the heart of most commercial vape cartridges lies a process called fractional distillation. It sounds complex, but the concept is straightforward. Imagine a sophisticated refinery for cannabis oil.

How it Works:
Fractional distillation separates the various components of crude cannabis oil based on their unique boiling points. The crude oil, often extracted using methods like CO2 or ethanol, is heated. As the temperature rises, compounds vaporise at different points.

  • Volatiles first: Lighter compounds, including some terpenes and solvents, boil off first.
  • The Goldilocks Zone: The process is tuned to target the boiling point of cannabinoids like THC or CBD.
  • Condensation: These specific vapours travel up a fractionating column, cool down, and condense back into a highly purified liquid.

The Result:
This method is incredibly effective at isolating specific cannabinoids, often achieving purity levels of 90-99%. It removes impurities, fats, waxes, and chlorophyll, resulting in that clear, golden oil we often see. This allows manufacturers to create products with very precise, standardised potency. A huge plus for consistent dosing.

The Catch:
While great for potency, fractional distillation has a downside: it strips away the plant’s soul. By isolating THC or CBD, the process often removes the original terpenes and minor cannabinoids that contribute to the “entourage effect” and the strain’s unique character. The resulting distillate is a blank slate, potent but flavourless and lacking the nuance of the original plant.

This is why, with pure distillate, it is impossible to know which plant material or strain was actually used. The unique fingerprint of “Durban Poison” or “White Widow” is largely erased in the pursuit of pure THC.

The Flavour Factor: Reintroducing Terpenes

To make this tasteless distillate enjoyable (and to mimic specific strains), manufacturers must reintroduce terpenes. This is where the quality divide widens significantly.

  • Botanical-Derived Terpenes (BDT): These are terpenes extracted from other plants (like lemons for limonene or lavender for linalool). They are cheaper and can create specific flavour profiles, but they often lack the complexity of cannabis. This is where you get vapes that taste like “Blueberry Blast” or “Mango Madness” flavours that don’t exist in the cannabis plant naturally.
  • Cannabis-Derived Terpenes (CDT): Premium brands will reintroduce terpenes extracted directly from cannabis. This offers a more authentic taste and potentially a better effect, but it’s still a reconstruction of the original profile.

My Rule of Thumb: If the flavour doesn’t exist in nature (like “Bubblegum Ice”), I steer clear. I want my cannabis vape to taste like cannabis.

The Premium Tier: Live Resin and Live Rosin

For those seeking the truest expression of the plant, Live Resin and Live Rosin vapes are the gold standard. These aren’t made using fractional distillation.

  • Live Resin: Made from fresh-frozen plant material (not dried and cured) using hydrocarbon extraction (like butane). Freezing preserves the volatile terpenes that are usually lost during drying. The result is a potent oil that captures the true aroma and full spectrum of the living plant.
  • Live Rosin: The pinnacle of purity. This is a solventless extract made by pressing fresh-frozen bubble hash under heat and pressure. It retains the maximum amount of terpenes, cannabinoids, and flavonoids without any chemical solvents. It is the closest experience to smoking the actual flower, offering a robust, complex high.

These products prioritise the entourage effect and the unique terroir of the cultivation, offering a depth of experience that distillate simply cannot match.

cannabis vape

The Hardware Hazard: Why Your Cart Matters

It’s not just about the oil; the vessel matters too. A premium extract in a cheap cartridge is a waste.

  • Plastic is a No-Go: Avoid cartridges with plastic tanks or airways. Terpenes are solvents themselves and can degrade plastic over time, leeching harmful chemicals into your oil.
  • Ceramic and Glass: Look for carts made with glass tanks and ceramic heating elements. These materials are inert, preserving the flavour and ensuring you’re inhaling only the vaporised oil, not burning wicks or melting plastic.
  • Airflow: A good cart should have decent airflow to prevent clogging, a common issue with thick oils.

Empowering Your Choice

So, how can you use this knowledge?

  1. Ask Questions: When buying a vape, ask, “Is this distillate, live resin, or live rosin?” Asking “Are the terpenes cannabis-derived?” is a great follow-up.
  2. Read the Label: Look for information on the extraction method. “Solventless” usually points to Rosin. “CO2 extracted” or “Ethanol extracted” often implies a distillate base, though not always.
  3. Trust Your Senses: If it tastes artificial, it likely is. If it makes you cough excessively or feels harsh, the hardware or the starting material might be subpar.
  4. Value the Source: Remember, with distillate, the origin strain is often lost. If you care about terroir and specific strain effects, lean towards Live Resin or Rosin, where the plant’s identity is preserved.

Vaping can be a fantastic, clean way to enjoy cannabis. By understanding the difference between a mass-produced distillate and a crafted live extract, you can ensure your hard-earned money goes towards a quality experience that respects the plant we love.

Posted on by

HHC: The Synthetic Ghost Haunting Our Shelves

HHC

This week, I found myself wandering into a vape shop. Fully stocked with all sorts of devices and vape carts. Flavours of all kinds. Mind you all, I am not a vapour? I think this is the term. But curiosity had me and a buddy stumble in. Upon walking in, we started chatting and being the weedy I am, I asked, “Are there THC vapes here?” The guy lit up and said: “No, but I have this, something better.” And handed me an HHC cart…

Naturally, I had to ask. “What can you tell me about this?”

The conversation that followed was, frankly, disheartening. The person selling this product had no idea what hydrogenation was, let alone why a synthetic derivative might be concerning to someone who values the natural plant. They couldn’t explain why we need to chemically alter a compound that nature already perfected. It was a stark reminder that while the shelves are filling up, the knowledge gap is widening.

We’ve touched on Hexahydrocannabinol (HHC) before, warning about its semi-synthetic nature and the grey market it inhabits. But encounters like this, coupled with emerging research from Europe, make it clear: we need to revisit this topic. We need to remind ourselves what HHC is, what it isn’t, and why the “legal” label doesn’t always mean “safe.”

What is HHC? A Quick Refresher

Let’s strip away the marketing. HHC is a semi-synthetic cannabinoid. While trace amounts can theoretically be found in the cannabis plant, the HHC you see on shelves is not natural. It is created in a lab through a process called hydrogenation.

Think of it like margarine. You take a natural oil (in this case, usually CBD extracted from hemp) and bombard it with hydrogen atoms using heavy metal catalysts (like palladium or nickel) under high pressure. This breaks the double bonds in the molecule, turning it into a more stable, hydrogen-saturated compound.

Why do they do this? Two reasons:

  1. Shelf Life: Hydrogenation makes the molecule incredibly stable. It resists oxidation, meaning it can sit on a shelf for months or years without degrading.
  2. Legal Loopholes: By chemically altering the structure, manufacturers create a compound that mimics THC’s effects but often slips through the cracks of specific drug laws at least until regulators catch up.
hhc

The New Reality: Poisonings and Public Health Alarms

While the salesperson in the vape shop might tell you it’s “just like THC but legal,” recent data tells a different, more alarming story. A study released in 2025 by the Czech Toxicological Information Centre (TIC) paints a grim picture of what happens when these semi-synthetic products flood an unregulated market.

Following the appearance of HHC products in the Czech Republic in 2022, the poison control centre saw a sharp rise in calls. We’re not talking about feeling a bit too sleepy; we’re talking about neurological, cardiovascular, and gastrointestinal toxicity.

The study analysed nearly 200 cases of HHC poisoning. The victims weren’t just seasoned users pushing limits; many were children and teenagers who consumed HHC in the form of gummies, cookies, and vape products identical to what I saw in that shop.

The symptoms reported were serious:

  • Neurological: 74% of patients experienced issues ranging from severe drowsiness and confusion to hallucinations and even seizures.
  • Cardiovascular: Over 40% suffered from tachycardia (rapid heart rate) and hypertension.
  • Gastrointestinal: Severe vomiting and nausea were common.

Crucially, the study highlighted that HHC intoxication can last significantly longer than THC intoxication. One case report detailed a healthy man in his 40s who consumed HHC cookies and suffered from cognitive and physical impairment for nine days. He experienced visual disturbances, disorientation, and an inability to function normally long after the “high” should have worn off. This prolonged effect is likely due to the structural changes from hydrogenation, which may alter how our bodies metabolise and eliminate the compound.

The “Entourage” vs. The Isolate

The beauty of the cannabis plant lies in its complexity. We’ve spent this year celebrating the Entourage Effect, the synergy between hundreds of cannabinoids, terpenes, and flavonoids working together. We’ve marvelled at the discovery of flavoalkaloids in natural leaves.

HHC products are the antithesis of this. They are typically made from isolates. You are getting a single, chemically modified molecule, stripped of the natural buffers and modulators found in the whole plant.

Furthermore, because HHC is synthesised, it exists in two forms (enantiomers): 9R-HHC and 9S-HHC.

  • 9R-HHC binds actively to your endocannabinoid receptors, mimicking THC.
  • 9S-HHC does not bind well and is largely inactive.

Commercial products are a mix of both. You have no idea what ratio you are getting, which leads to wildly inconsistent effects. One vape cart might do nothing; the next might send you to the ER with panic attacks and heart palpitations because the batch had a higher ratio of the active 9R isomer.

Why Are We Seeing It Here?

You might ask, “If we have access to amazing, natural South African cannabis, why is this stuff here?”

The answer is simple: Economics and Opportunism.
The 2018 US Farm Bill legalised hemp cultivation, leading to a massive surplus of CBD. Chemists realised they could convert this cheap CBD into psychoactive HHC and sell it in markets where THC is restricted or where “legal” sounds safer to the uninitiated consumer.

It is a product born from a loophole, not from a love for the plant. The process was founded with the intention of creating stable medicine. things similar to Marinol. We all know how that turned out.

hhc

The Verdict: Keep It Real

The encounter at the vape shop was a wake-up call. It showed that while the culture is growing, so is the misinformation.

As a community that prides itself on understanding the plant, from the soil microbiome to the terpene profile, we need to be discerning.

  • HHC is not “natural weed.” It is a lab-made chemical analogue.
  • It carries risks. The potential for contaminants (heavy metals from the hydrogenation process) and the documented cases of severe, prolonged intoxication are real.
  • We have better. We live in a country with some of the best sun-grown genetics on earth. Why trade the rich, therapeutic complexity of a Durban Poison or a well-grown White Widow for a synthetic mystery fluid?

Let’s stick to what we know, what we love, and what the earth provides. Let’s keep our culture green, not grey. Stay safe, stay informed, and keep it natural.

Posted on by

The High Street Revolution: South Africa’s Cannabis Retail

Cannabis retail

If you’ve driven through your local town or city centre lately, you’ve likely noticed a distinct shift in the retail landscape. The green neon signs are flickering on, not just in hidden alleyways, but on main roads and in shopping centres. Cannabis shops and dispensaries are opening up left, right, and centre across South Africa. Just within a short radius of where I sit writing this, I can count five or six new spaces that have popped up recently.

As we settle into 2026, the retail face of cannabis in our country is evolving at a breakneck speed. But beneath the shiny counters and jar-lined shelves lies a complex, often confusing, and incredibly dynamic ecosystem. This week, we aren’t looking at the plant in the soil, but rather how it gets into your hands. Let’s unpack the current state of South African dispensaries, the economics of selling flower, and the battle for quality.

The Legal Grey Area: Prescription vs. Membership

The most intriguing aspect of this retail boom is the legal framework and the creative navigation of it. Currently, the only strictly legal route to purchasing cannabis is through a Section 21 framework, which dispenses cannabis as a prescribed medicine.

However, walk into many of these new stores, and you won’t always see a doctor. Instead, you see a variety of “membership models,” private clubs, and spaces operating in a “tolerated” grey zone. It is clear from the Gazette Law that cannabis can be cultivated in private, but the sale thereof remains illegal. Despite the regulatory hurdles, these shops remain open and operational. Some face the occasional brush with the law, while others seem to operate with impunity.

Our store has successfully navigated this space for the last two years, serving a community from farm to table, cutting out the middleman. This year, we will be making changes to The Certified ZA, the model for procurement will change, but the quality will remain. In fact, we will become even more affordable in 2026. But for others, this year will remain consistent, and they expect the output of stores to increase. But with this, it begs the question: if the law is clear, why are the shops so plentiful? The answer lies in the undeniable voice of the consumer.

cannabis retail

The Unstoppable Demand

The sheer volume of cannabis being consumed in South Africa remains a mystery to statisticians, but for those of us on the ground, one thing is certain: it is increasing. There is a massive, unfulfilled need for flower daily.

The proliferation of shops proves that there are still spaces to create and people to reach. The stigma is evaporating, replaced by a normalised culture of consumption for health, relaxation, and creativity. The market is far from saturated in terms of consumer desire, even if it is becoming crowded with retail fronts.

The Business Reality Check: Overheads vs. Pricing

To anyone looking at these new shops and dreaming of opening their own: proceed with caution. The “Green Rush” has a steep barrier to entry, and it isn’t always the law—it’s the overheads.

Selling weed sounds like a license to print money, but selling weed to cover commercial rent, electricity, staffing, and security is a different beast entirely. Many new entrants haven’t realised this, leading to a flawed game plan where the consumer pays the price. To cover massive overheads, some shops are drastically overcharging for flower.

This creates a frustrating “cat and mouse” game. Shops push products to pay the bills, but the average consumer finds the pricing unsustainable. Cannabis is meant to be the people’s plant, not a luxury good priced out of reach of the daily consumer. The shops that survive 2026 will be the ones that figure out how to balance business costs with fair, accessible pricing.

The Quality Lottery

Walk into Store A, and you might find impeccably cured, terpene-rich, top-shelf indoor hydro that rivals the best in the world. Walk into Store B down the road, and you might be met with dry, brown, outdoor bush sold at indoor prices.

Currently, there are no real standardised quality controls across the board. Is this an issue? Or is it a feature of a free market?
On one hand, having “something for everyone” is good; not everyone needs or wants 30% THC boutique flower. On the other hand, a lack of standards creates a lack of trust. If a consumer buys a “premium” gram that turns out to be harsh and unflushed, it hurts the reputation of the entire legal(ish) industry. I haven’t fully made up my mind on whether this wild-west variety is a net positive or negative, and I would love to hear your thoughts in the comments. Does something like this even matter to you?

The Rise of the Franchise

We are also witnessing the “Starbucks-ification” of South African cannabis. Franchise brands are aggressive, opening multiple spaces in close proximity or scattering them across regions to capture maximum foot traffic.

There is a benefit here: Brand Recognition. For a new user, walking into a known franchise feels safer and more legitimate than entering a nondescript store with blacked-out windows. However, these chains often face backend problems. Managing multiple partnerships, high staff turnover, and massive overheads is chaotic.

Furthermore, we see product stagnation. When every shop in a 12-store franchise carries the exact same strains from the same supplier, the magic of discovery dies. Opening more stores isn’t always the solution if the product inside doesn’t evolve.

Cannabis Retail

The Outlook for 2026

I visited a new shop just two days ago. Nice little store, family-run and owned. Goodluck to them. Because down the street, I learned a franchise also opened, which is the 12th store opening for that specific franchise within a 30km radius. The saturation in some hubs is real.

As we move through 2026, we will likely see more doors open, but we will also see doors close. The market will naturally correct itself. The shops that will remain standing won’t necessarily be the ones with the deepest pockets or the flashiest neon signs.

Success will be directly correlated to how they treat people and if they truly understand the plant.

Can the budtender explain the difference between a terpene profile for sleep versus one for creativity? Do they respect the consumer’s budget? Is the vibe welcoming or transactional? The future belongs to the spaces that combine fair pricing, quality control, and a genuine passion for cannabis culture.

Support the shops that support the culture. Support the spaces that respect the plant.

Posted on by

New Hope for Knees? Unpacking the Latest Clinical Trial on CBD

CBD

As we embrace the fresh start of 2026, many of us are looking for new ways to enhance our health and well-being. For those battling the persistent ache of osteoarthritis, particularly in the knees, the quest for relief is often top of mind. In South Africa, where an active lifestyle is cherished, joint pain can be a significant hurdle.

Late last year, a new clinical trial titled “Effects and safety of a CBD-rich Cannabis sativa oil in knee osteoarthritis” (the CANOA trial) was published, adding a crucial piece to the puzzle of cannabis medicine. Conducted by researchers at the Universidade Federal da Integração Latino-Americana in Brazil, this double-blind, randomised, placebo-controlled study offers valuable insights into the potential and the limitations of CBD oil for pain management.

This week, we’re diving deep into this study to understand what it means for patients, the medical community, and the future of cannabis-based therapies for osteoarthritis.

The Challenge: Living with Osteoarthritis

Osteoarthritis is a degenerative joint disease that affects millions worldwide, causing chronic pain, inflammation, and reduced mobility. Conventional treatments often rely on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or opioids. While these can provide relief, they often come with significant long-term side effects, leaving many patients searching for safer, more sustainable alternatives.

Enter cannabis. With its well-known anti-inflammatory and analgesic properties, the cannabis plant has emerged as a beacon of hope. Specifically, Cannabidiol (CBD), a non-intoxicating compound, has shown promise in preclinical studies. However, rigorous clinical evidence in humans has remained scarce and sometimes contradictory. The CANOA trial aimed to fill this gap.

CBD

The Study: Testing a Full-Spectrum Solution

The CANOA trial was meticulously designed to test the efficacy and safety of a full-spectrum CBD-rich cannabis oil. Unlike isolated CBD products, full-spectrum oils contain a range of phytocannabinoids, terpenes, and flavonoids. This composition is believed to leverage the “entourage effect,” where these compounds work synergistically to enhance therapeutic benefits.

Key Study Details:

  • Participants: 45 patients aged 30-70 with diagnosed knee osteoarthritis and moderate-to-severe pain.
  • The Treatment: Participants were randomly assigned to receive either the cannabis oil (containing 45 mg of CBD daily) or a placebo (MCT oil) for 60 days. Crucially, the oil contained virtually no THC (below detection limits), isolating the potential effects of CBD and other minor cannabinoids.
  • Measurement: The primary goal was to measure changes in pain intensity using the WOMAC scale, a standard tool for assessing osteoarthritis. Secondary measures included quality of life, sleep quality, and depression levels.

The Findings: Relief, But No “Magic Bullet”

The results of the CANOA trial are fascinating and nuanced.

  1. Pain Relief was Universal:
    At the end of the 60-day trial, both groups reported a significant reduction in pain. Patients taking the CBD oil experienced relief, but so did those taking the placebo. Statistically, there was no significant difference in pain reduction between the two groups.
  2. Quality of Life Improvements:
    Similarly, both groups reported improvements in sleep quality, depression symptoms, and overall quality of life. Again, the cannabis oil did not outperform the placebo in these metrics.
  3. The Power of the Placebo:
    The researchers highlighted a strong “placebo effect” and potentially the “Hawthorne effect” (where individuals modify an aspect of their behavior in response to their awareness of being observed). The care, attention, and positive expectations associated with participating in a clinical trial can themselves be powerful healers.
  4. Safety and Tolerability:
    This is a critical win. The CBD-rich oil was exceptionally well-tolerated. No serious adverse events were reported, and blood tests showed no negative impact on liver or kidney function. The most common side effects were mild, such as dry mouth or slight weight changes, but these were comparable to the placebo group. This confirms the high safety profile of CBD, a vital consideration for long-term use.
CBD

What Does This Mean for You?

The CANOA trial might seem discouraging at first glance—after all, the CBD oil didn’t beat the placebo. However, it provides essential context for managing expectations and refining treatments.

  1. Dosage Matters:
    The study used a daily dose of 45 mg of CBD. While safe, this might be too low for severe osteoarthritic pain. Cannabis medicine is highly individualised, and higher doses or different formulations might be necessary to unlock significant analgesic effects.
  2. The “Entourage” Needs THC?
    The oil used had undetectable levels of THC. Many experts argue that a small amount of THC is crucial to fully activate the entourage effect and provide potent pain relief. Future research needs to explore formulations with balanced ratios of CBD and THC.
  3. It’s Safe to Try:
    The study reinforces that high-quality CBD oil is safe. For those struggling with osteoarthritis, it remains a low-risk option to explore, potentially as an add-on to other therapies. While it might not be a cure-all on its own at this dosage, its safety profile makes it a viable candidate for personalised medicine approaches.
  4. The Mind-Body Connection:
    The strong placebo response underscores the importance of holistic care. Managing chronic pain isn’t just about molecules; it’s about patient support, mental well-being, and the therapeutic relationship.
CBD

Looking Ahead

The CANOA trial is a stepping stone, not a roadblock. It challenges the cannabis community to look deeper to investigate higher dosages, different cannabinoid combinations (like adding THC, CBG, or CBC), and longer treatment periods.

As we move through 2026, let’s use this knowledge to advocate for more research and to approach cannabis medicine with both optimism and a critical scientific eye. For now, the takeaway is clear: CBD is safe and holds potential, but finding the “sweet spot” for osteoarthritis relief is a journey we are still navigating.

Posted on by

Roots, Resin, and Revolution: A Chronicle of South African Cannabis in 2025

cannabis in 2025

As the final, golden sun of 2025 dips below the horizon, casting long shadows across our veld, mountains, and coastlines, a collective pause washes over the South African cannabis community. New Year’s Eve is more than just a celebration of the turning calendar; for us, it is a harvest of memories, lessons learned in the garden, and the appreciation of a culture that has grown stronger, smarter, and more vibrant over the last twelve months.

This year wasn’t just another lap around the sun. It was a year where ancient wisdom shook hands with cutting-edge science. We didn’t just grow weed; we deconstructed it, analysed it, respected it, and ultimately, mastered it. From the microscopic alchemy within a single trichome to the gravitational pull of the moon, we expanded our horizons.

Before we light up the first joint (or rip the first bong) of 2026, let’s take a deep breath and look back at the incredible journey we’ve shared. Here is the definitive recap of our year in green.

Unlocking the “Unseen Signature”: Science Meets Soil

We began our journey by looking inward, past the psychoactive buzz, to the nutritional marvel that started it all: The Hemp Seed. We moved beyond viewing seeds merely as a means to an end, recognising them as a complete nutritional powerhouse, packed with essential proteins and a perfect ratio of Omega fatty acids. It set the stage for a year of looking deeper.

That depth was realised when we broke the story on the groundbreaking research coming out of Stellenbosch University. This wasn’t just global news; it was our news. The discovery of flavoalkaloids—rare, hybrid compounds found predominantly in cannabis leaves—shattered the notion that the flower is the only valuable part of the plant. It proved what many of us suspected: the “entourage effect” is far more complex than we imagined, and South African genetics holds secrets the world is only just beginning to understand.

This led us naturally to the concept of Terroir. We explored how the unique red soils of the north, the humidity of the east coast, and the Mediterranean climate of the Cape imprint an “unseen signature” on our plants. We learned that you can clone a gene, but you cannot clone a place. This biochemical fingerprint is what makes South African cannabis unique on the global stage.

Environmental Controls for cannabis

The Cultivator’s Almanack: Rhythms and Regulations

No recap of 2025 would be complete without acknowledging how we refined our cultivation methods. We looked to the heavens, debating the merits of Celestial Gardening. We unpacked the ancient practice of planting by the Spring Equinox and the Lunar Cycles, understanding that while modern physics might debate the gravitational pull on sap, the discipline and observation required by biodynamic farming undeniably lead to better harvests.

But we grounded this cosmic approach with hard agricultural science. We navigated the regulatory maze of the Fertiliser Act 36 of 1947, specifically demystifying Group 3 Fertilisers. We learned that organic does not mean unregulated, and that biofertilizers and soil enhancers are the keys to unlocking genetic potential.

We met the “Unseen Heroes” of the soil: Humic and Fulvic Acids. We distinguished the Architect (Humic) from the Courier (Fulvic), realising that building soil structure and ensuring nutrient delivery are two sides of the same coin. We also mastered the use of Gibberellic Acid (GA3), the unseen architect of plant geometry, learning how to use this powerful hormone to break dormancy and stretch vegetation without compromising quality. We even took time to discuss Auxins. So check that out.

The Plant’s Language: Morphology and Metamorphosis

Perhaps the most profound lesson of the year was learning to speak the plant’s language. We dove into Plant Morphology, tracing the fascinating journey of leaf complexity—from the single serrated leaflet of a seedling to the nine-fingered glory of vegetative peak, and the natural regression during senescence.

We discussed Source-Sink Dynamics, realising that a plant is an economy of energy. We learned to spot when a plant is “sink-limited”—having plenty of leaves but unable to push energy to the flowers—and how nutrient uptake (specifically Phosphate loading) plays a critical role in this balance. We even touched on the speed-freaks of the garden, Autoflowers, and how their internal “florigen” timer sets them apart from their photoperiod cousins.

The Culture: From Extraction to Inhalation

Finally, we celebrated the culture that binds us. The 8th Annual Amber Cup at The Jazzfarm was a highlight, a testament to how far we have come from the days of stigma to a celebration of world-class extraction artistry. We celebrated our own award-winning extracts, not out of vanity, but as proof that scientific rigour and passion yield gold.

And, of course, we debated the ritual. We analysed the Bong vs. the Joint vs. the Pipe. We validated the joint roller’s meditative craft and the bong smoker’s quest for instant, high-fidelity flavour. We agreed that whether you are crushing a technical clutch-pull or passing a fishtail joint around a braai, the destination is the same: appreciation of the plant.

A Toast to 2026

As we close the book on 2025, we do so with soil under our fingernails and knowledge in our minds. We are no longer just growing weed; we are cultivating medicine, food, and culture. We are operating at the intersection of ancestral wisdom and future-tech science.

cannabis season